This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
The Indian benchmark indices continue to trade on a positive note this Monday afternoon with the Nifty adding 60 points and is trading at 10,832 mark. The Sensex is trading higher by 204 points at 35,861.
IOC 500408 PAGEIND 500325 JISLJALEQS ASIANPAINT 533137 CADILAHC 533248 DEN SYNDIBANK 534976 JUSTDIAL 532321 521070 JBFIND 500378 GAILF RLNIY SBAZ 500219 PGDQY AXB RELCAPITAL 524804 532827 YYBKY 530965 530005 531213 AXBA 532276 TATASTEEL TATLY GAMMONIND JINDALSAW ALOKTEXT GAILY 509550 TCS 500188 HINDZINC 524715 HINDCOPPER 500820 532939 AUROPHARMA RELIANCE IDBI GPPL HNDZY 532856 514034 TTNQY 532215 500470 532540 535648 532461 AXISBANK INOXWIND RIGD MANAPPURAM INDIACEM 500111 YESBANK RPOWER 570004 500116 IBN 513599 532648 CDLYY AXBKY VMART ICICIBANK TTST PNJZY 532174 JISLDVREQS ARBQY SUNPHARMA TATAELXSI PNB 539083 JSTQY TIMETECHNO
The bulls have taken complete control of Dalal Street this Friday afternoon with the Nifty jumping 109 points at 10,698 and the Sensex is trading higher by 363 points at 35,401.
BAJAJ-AUTO AMKD 500325 533096 UBL CAPF BRTQY TCHQY JISLJALEQS ICLQY 532712 532755 532478 532960 SYNDIBANK RCOM 534816 500696 500378 GAILF 500570 BRITANNIA RLNIY ASHOKLEY SBAZ 500219 EXIDEIND PTC JETAIRWAYS 532822 AKLD TECHM CASTROLIND EXQDY 532276 TATASTEEL TATLY JINDALSAW 500180 GAILY 507458 AKLS ANDHRABANK 500825 HINDCOPPER BHRYY 532938 GODREJIND RELIANCE IDBI 532617 532418 AMTEKAUTO HINDUNILVR 532977 IDBLZ CSLQY 500470 532461 RIGD INFRATEL HDFCBANK 500477 TATAMOTORS 500870 570004 HINDALCO 500116 IBVENTURES IBN UBHOLDINGS 513599 532524 UNBWY HNDNF ICICIBANK TTST PNJZY HDB 532174 JISLDVREQS IDEA PNB ADANIPOWER 520077 500086 500164 500440 TTM
Market Update: European markets were trading higher amid uncertainty over whether OPEC would manage to increase crude output at a meeting in Vienna later in the day. Britain's FTSE and France's CAC were up 0.7 percent at the time of writing this article.
500325 HCTHY 535789 534816 500135 532281 500378 BJJQY RLNIY AXB UNITDSPR ESSELPRO JETAIRWAYS CANFINHOME 511196 531213 532432 AXBA BAJFINANCE FORTIS JINDALSAW HCLTECH 500180 UQNTY BHRYY 539254 RELIANCE IDBI 532617 531768 533155 BHRQY JUBLFOOD 532215 AXISBANK RIGD JBLWY MANAPPURAM INFRATEL HDFCBANK BHARTIARTL 500034 ADANITRANS INDIGO 500116 IBN IDKQY 532843 539448 AXBKY IBULHSGFIN 532454 ICICIBANK HDB 532174 POLYMED
Market Check: Equity benchmarks are trading at the high points of the day, with the Nifty hitting 10,800-mark now. The Sensex is up over 100 points. Strong gains in financials, namely PSU banks, is aiding sentiment on D-Street. Sharp upmoves are visible in sectors such as pharma, FMCG, energy and infra names. Midcaps too have added to their gains, trading around quarter of a percent higher. Sun Pharma is leading the gainers chart on Sensex and Nifty, followed by Bajaj Finance and M&M, while Reliance, Wipro, and HPCL have lost the most.
BHRYY 500325 500228 RELIANCE IDBI HCTHY 512573 532714 531768 500470 GRANULES 532482 534816 RIGD 500135 532281 HDFCBANK 500378 BJJQY INFRATEL KEC RLNIY 500034 500116 AVANTI IBN ESSELPRO JSWSTEEL ICICIBANK BAJFINANCE TTST TATASTEEL TATLY HDB 532174 500180 JINDALSAW HCLTECH 534809 PCJEWELLER POLYMED
IPO Subscription: The issue of Fine Organics was fully subscribed on the third day its initial public offering (IPO) on last day today.
BHRYY 500325 500228 RELIANCE IDBI 533273 HCTHY 512573 532714 531768 500470 GRANULES 532482 534816 RIGD 500135 532281 HDFCBANK 500378 BJJQY INFRATEL KEC RLNIY 500034 500116 AVANTI IBN ESSELPRO JSWSTEEL ICICIBANK OBZIY BAJFINANCE TTST OBEROIRLTY TATASTEEL TATLY HDB 532174 500180 JINDALSAW HCLTECH 534809 PCJEWELLER POLYMED
Jindal Saw in focus: Pipe manufacturer Jindal Saw said it is currently not exporting large diameter pipes to the United States and the countervailing duty imposed by the US won't have any impact on company's business.
BHRYY 500325 500228 RELIANCE IDBI 533273 HCTHY 512573 532714 500470 GRANULES 532482 534816 RIGD 500135 532281 HDFCBANK 500378 BJJQY INFRATEL KEC RLNIY 500034 500116 AVANTI IBN ESSELPRO JSWSTEEL ICICIBANK OBZIY BAJFINANCE TTST OBEROIRLTY TATASTEEL TATLY HDB 532174 500180 JINDALSAW HCLTECH 534809 PCJEWELLER
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
AstraZeneca Pharma India on Friday said that it has received approval from the Drug Controller General of India to market Durvalumab, a cancer treatment medicine. The nod paves the way for it to launch the product in the country. Durvalumab is indicated as a treatment option for patients with locally-advanced, unresectable non-small cell lung cancer and metastatic urothelial carcinoma. Shareholders will closely monitor the development.
JINDALSAW 500378 ASTRAZEN 506820
Atishay has won the project for providing technical support services for Rajasthan UID (Aadhaar) through open competitive bidding (e-tender). The total price consideration for the project is about ₹1.40 crore, it said in a disclosure to the BSE. The company has to deploy technical resources at the client site (Department of Information Technology Communication, Jaipur). The deployed resources will provide proactive assistance to the concerned officials for successful implementation of UID technical projects in Rajasthan.
Strides Shasun on Friday announced the receipt of prequalification from the World Health Organisation for its 100-mg rectal artesunate suppositories for pre-referral management of severe malaria. Achieved with support from MMV and funding from Unitaid, this prequalification enables countries to procure life-saving RAS with donor funding, thus ensuring increased access to this potentially life-saving intervention, Strides Shasun said.
The board of DIL on Thursday approved a scheme of amalgamation with its subsidiary Fermenta Biotech, a manufacturer/marketer of bulk drugs including Vitamin D3 and enzymes. Under the terms, 100 equity shares of DIL of ₹10 each would be issued for every 1,006 equity shares of FBL. As the board on June 18 recommended a stock split (to ₹5) and 1:1 bonus, FBL shareholders would receive 100 DIL shares for every 251 shares held in FBL.
The dollar powered to an 11-month high in the currency market, maintaining pressure on inflation and on countries and firms that have gorged themselves on dollar-denominated debt in recent years.
FOX CCV.CL CCV CMCSA JINDALSAW CCZ 500378 FOXA CMCSK DIS
KNR in focus: In a clarification note to the exchanges regarding "Promoters of Company taking large interest free loan from the Company", KNR Constructions said the promoters have extended unsecured loan of Rs 214.08 crore to the company, at the interest rate of 8.45 percent per annum to defray the term loan of one of the SPV. "There are no loans and advances given by the Company to promoters."
OPTOCIRCUI 500325 RELIANCE IDBI 539254 533155 JUBLFOOD 511288 CMQMY RIGD JBLWY CUMMINSIND HDFCBANK 500378 RLNIY SBAZ ADANITRANS GRUH INDIGO 500116 534690 IBN GRHFY 532942 539207 539448 KNRCON 500480 ICICIBANK LAKSHVILAS HDB 532174 500180 JINDALSAW 532391 MANPASAND
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...